
30/07/2025
Learn more about circulating (s100a8/a9) in rheumatic diseases and how the biomarker reflects local joint inflammatory activity!
๐ฉ๐ถ๐๐ถ๐ ๐ฝ๐ผ๐๐๐ฒ๐ฟ ๐๐ฒ๐๐๐ถ๐ผ๐ป ๐-๐ฌ๐ด๐ฎ ๐๐ผ๐ฑ๐ฎ๐: Serum calprotectin in systemic and autoimmune pediatric diseases: a promising biomarker for detection of inflammation and assessment of disease activity ๐ July 30 | 1:30โ2:30 PM
๐ฅ๐ฒ๐ฐ๐ผ๐บ๐บ๐ฒ๐ป๐ฑ๐ฒ๐ฑ ๐ถ๐ป ๐ฐ๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น ๐ด๐๐ถ๐ฑ๐ฒ๐น๐ถ๐ป๐ฒ๐: Both the American College of Rheumatology (ACR) and the European Alliance of Associations for Rheumatology (EULAR) in collaboration with the Paediatric Rheumatology European Society (PReS) have highlighted calprotectin as one of the new biomarkers strongly recommended in managing rheumatic diseases:
๐ฉ๐ผโ๐ฌDirectly reflecting local joint inflammatory activity
๐ฉ๐ผโ๐ฌSensitive marker even for subclinical disease activity
๐ฉ๐ผโ๐ฌRisk marker for disease flares
๐ฉ๐ผโ๐ฌGuide for treatment decisions
More information ๐https://www.gentian.com/hubfs/Circulating%20calprotectin%20for%20LinkedIn%20ADLM2025.pdf
Meet our team at the poster session or booth #3503.
๐ฉ๐ผโ๐ฌ
๐ณ๐๐พ ๐ฆ๐พ๐๐๐๐บ๐ ๐ฆ๐ข๐ ๐ซยฎ ๐ข๐บ๐
๐๐๐๐๐พ๐ผ๐๐๐ ๐จ๐๐๐๐๐๐บ๐๐๐บ๐ ๐๐ ๐๐๐ ๐ผ๐
๐พ๐บ๐๐พ๐ฝ ๐ฟ๐๐ ๐๐บ๐
๐พ ๐๐ ๐๐๐พ ๐ด๐๐๐๐พ๐ฝ ๐ฒ๐๐บ๐๐พ๐. ๐ณ๐๐พ ๐บ๐๐๐บ๐ ๐๐ ๐ข๐ค-๐๐บ๐๐๐พ๐ฝ ๐๐ ๐ผ๐๐๐๐
๐๐บ๐๐ผ๐พ ๐๐๐๐ ๐จ๐ต๐ฃ๐ฑ ๐ค๐ข๐ฃ๐ฉ/๐ฉ๐ฆ๐จ (๐ข๐ค ๐ข๐ฃ๐ค๐ฅ).